INNOVATE Naples - Paolo Ascierto hosts clinician/researchers discussing #CANCER #NEOADJUVANT #immunotherapy. Favorite meeting for patient-centered novel trials. Discussed optimising immunotherapy across multiple cancers & #melanoma to cure more Grazie tutti!
INNOVATE Naples - Paolo Ascierto hosts clinician/researchers discussing #CANCER #NEOADJUVANT #immunotherapy. Favorite meeting for patient-centered novel trials. Discussed optimising immunotherapy across multiple cancers & #melanoma to cure more Grazie tutti!
@sydneyuni.bsky.social @melanomaau.bsky.social
www.nature.com/articles/s41...
@sydneyuni.bsky.social @melanomaau.bsky.social
www.nature.com/articles/s41...
@sydneyuni.bsky.social @wehi-research.bsky.social @jimwhittle.bsky.social @braincancercentre.bsky.social @melanomaau.bsky.social @science.org.au @ascocancer.bsky.social @ascopost.bsky.social @sitcancer.bsky.social
@science.org.au
Ipilimumab + nivolumab vs nivolumab in patients with #melanoma brain metastases (ABC): 7-yr follow-up of randomised, ph 2 study - The Lancet Oncology www.thelancet.com/journals/lan...
@science.org.au
Ipilimumab + nivolumab vs nivolumab in patients with #melanoma brain metastases (ABC): 7-yr follow-up of randomised, ph 2 study - The Lancet Oncology www.thelancet.com/journals/lan...
youtu.be/VfJKuE114Do?...
youtu.be/VfJKuE114Do?...
www.nejm.org/doi/abs/10.1...
www.nejm.org/doi/full/10....
www.annalsofoncology.org/article/S092...
ascopubs.org/doi/10.1200/...
ascopubs.org/doi/10.1200/...
www.nature.com/articles/s41...
www.nejm.org/doi/abs/10.1...
www.nejm.org/doi/full/10....
www.annalsofoncology.org/article/S092...
ascopubs.org/doi/10.1200/...
ascopubs.org/doi/10.1200/...
www.nature.com/articles/s41...